Adage Capital Partners Gp, L.L.C. Werewolf Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,000,594 shares of HOWL stock, worth $5.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000,594
Previous 3,000,594
33.33%
Holding current value
$5.44 Million
Previous $19.4 Million
74.9%
% of portfolio
0.01%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding HOWL
# of Institutions
75Shares Held
32.1MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$16.7 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$11.7 Million5.74% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$8.82 Million0.41% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$6.5 Million0.94% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$5.84 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $80.3M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...